David Churchill

Brown Advisory, Inc. provides investment and advisory services. It specializes in investment management, strategic advisory, wealth management, and private equity. The firm provides services to individuals, families, institutions, and corporations. The company was founded in 1993 and is headquartered in Baltimore, MD.

Part of Brown Advisory, Inc., Axiom Direct Investors LLC operates as a private equity fund. The company is based in Baltimore, MD. The CEO of the company is Michael David Hankin.

NextGen Pluto LLC, a special purpose vehicle formed to make investment in Pluto Health Inc.

Part of Brown Advisory, Inc., PathAI Investors LLC functions as a private equity fund. The company is based in Baltimore, MD. The CEO of the company is Michael D. Hankin.

Nextgen Sunroom LLC, a special purpose vehicle formed to make investment in B&Z Homes, Inc.

Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019.